ANTIVA Trademark

Trademark Overview

On Monday, September 14, 2015, a trademark application was filed for ANTIVA with the United States Patent and Trademark Office. The USPTO has given the ANTIVA trademark a serial number of 86755911. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, October 10, 2025. This trademark is owned by Antiva Biosciences, Inc.. The ANTIVA trademark is filed in the Pharmaceutical Products category with the following description:

antivirals; pharmaceutical preparations, namely, antivirals; pharmaceutical preparations to inhibit HPV, for the prevention and treatment of pre cancer and genital warts; antiviral preparations; therapeutic pharmaceuticals to inhibit HPV, for the prevention and treatment of pre cancer and genital warts; pharmaceutical products for the treatment of viral and infectious diseases, and for the treatment of pre cancer; pharmaceutical preparations and substances for the treatment of viral and oncological related diseases and disorders
antiva

General Information

Serial Number86755911
Word MarkANTIVA
Filing DateMonday, September 14, 2015
Status710 - CANCELLED - SECTION 8
Status DateFriday, October 10, 2025
Registration Number5710015
Registration DateTuesday, March 26, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 9, 2016

Trademark Statements

Goods and Servicesantivirals; pharmaceutical preparations, namely, antivirals; pharmaceutical preparations to inhibit HPV, for the prevention and treatment of pre cancer and genital warts; antiviral preparations; therapeutic pharmaceuticals to inhibit HPV, for the prevention and treatment of pre cancer and genital warts; pharmaceutical products for the treatment of viral and infectious diseases, and for the treatment of pre cancer; pharmaceutical preparations and substances for the treatment of viral and oncological related diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, October 10, 2025
Primary Code005
First Use Anywhere DateWednesday, August 23, 2017
First Use In Commerce DateWednesday, August 23, 2017

Trademark Owner History

Party NameAntiva Biosciences, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameAntiva Biosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameAntiva Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Thursday, September 17, 2015NEW APPLICATION ENTERED
Thursday, September 17, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 29, 2015ASSIGNED TO EXAMINER
Wednesday, January 6, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 20, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, June 24, 2016EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, February 9, 2016PUBLISHED FOR OPPOSITION
Tuesday, February 9, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 1, 2016EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, August 9, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, February 2, 2017SOU TEAS EXTENSION RECEIVED
Thursday, February 2, 2017SOU EXTENSION 1 FILED
Thursday, February 2, 2017SOU EXTENSION 1 GRANTED
Saturday, February 4, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 25, 2017SOU TEAS EXTENSION RECEIVED
Tuesday, July 25, 2017SOU EXTENSION 2 FILED
Tuesday, July 25, 2017SOU EXTENSION 2 GRANTED
Thursday, July 27, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 8, 2018SOU TEAS EXTENSION RECEIVED
Thursday, February 8, 2018SOU EXTENSION 3 FILED
Thursday, February 8, 2018SOU EXTENSION 3 GRANTED
Saturday, February 10, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 5, 2018TEAS STATEMENT OF USE RECEIVED
Thursday, July 5, 2018USE AMENDMENT FILED
Tuesday, July 31, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, July 31, 2018STATEMENT OF USE PROCESSING COMPLETE
Monday, August 20, 2018SU - NON-FINAL ACTION - WRITTEN
Monday, August 20, 2018NON-FINAL ACTION E-MAILED
Monday, August 20, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, January 31, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 31, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 1, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 20, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, February 21, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, March 26, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, March 26, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, October 10, 2025CANCELLED SEC. 8 (6-YR)

Related Keywords

antiva treatment preparations pharmaceutical cancer inhibit antivirals viral genital warts diseases